跳至主要内容
临床试验/CTRI/2019/07/019972
CTRI/2019/07/019972尚未招募未知

Assessment of patoladi kwatha in vaatarakta in comparison with febuxostat with special reference to gout - A randomized controlled clinical trial

Dr Rukhsar Sheikh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either gender
  • Patients with age 18 to 70 years
  • Serum uric acid level >7 mg / dl for men and > 6 mg / dl for women
  • Chronic cases of gout ( more than 1 year )

排除标准

  • Immunocompromised patients or patients on immunosuppressive drugs
  • Patients suffering from life threatening diseases
  • Pregnant women and lactating mother
  • Patients with k/c/o hypersensitivity of any drug
  • Patients suffering from chronic kidney diseases or end stage renal diseases and requiring dialysis
  • Patients taking diuretics, aspirin, ethambutol, pyrazinamide, cyclosporine, cytotoxic drug

研究者

发起方
Dr Rukhsar Sheikh

相似试验